Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Clobetasol

Insgesamt 109 ergebnisse

NCT03847389

Beendet

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Bedingungen: Atopic Dermatitis
NCT04246801

Rekrutierung

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)

Bedingungen: Cataract
NCT04249076

Rekrutierung

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

Bedingungen: Cataract
NCT02573883

Abgeschlossen

Clobetasol Proprionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus

Bedingungen: Vulvar Lichen Sclerosus
NCT01703325

Abgeschlossen

Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails

Bedingungen: Psoriatic Nails
NCT00733954

Abgeschlossen

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Bedingungen: Plaque Psoriasis
NCT00842153

Abgeschlossen

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Bedingungen: Psoriasis
NCT00828464

Abgeschlossen

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Bedingungen: Hand Dermatosis
NCT00864240

Abgeschlossen

The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Bedingungen: Healthy
NCT00864500

Abgeschlossen

Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Bedingungen: Healthy
NCT01893567

Abgeschlossen

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Bedingungen: Plaque Psoriasis
NCT02131324

Abgeschlossen

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Bedingungen: Psoriasis
NCT03453190

Unbekannter Status

Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

Bedingungen: Psoriasis
NCT01557517

Abgeschlossen

Clobetasol for Oral Graft-Versus-Host Disease

Bedingungen: Oral Chronic Graft vs Host Disease
NCT00852761

Abgeschlossen

A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Bedingungen: Plaque-Type Psoriasis
NCT01111981

Unbekannter Status

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

Bedingungen: Alopecia
NCT00988637

Abgeschlossen

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

Bedingungen: Plaque Psoriasis
NCT02744378

Abgeschlossen

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

Bedingungen: Oral Lichen Planus
NCT00436540

Abgeschlossen

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Bedingungen: Psoriasis
NCT01699412

Abgeschlossen

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Bedingungen: Graft vs Host Disease; Oral Manifestations
NCT00881868

Abgeschlossen

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Bedingungen: Scalp Psoriasis
NCT02319616

Zurückgezogen

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Bedingungen: Toxic Epidermal Necrolysis
NCT00658788

Abgeschlossen

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Bedingungen: Psoriasis
NCT00757874

Abgeschlossen

Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus

Bedingungen: Vulvar Lichen Sclerosus
NCT01745133

Abgeschlossen

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis

Bedingungen: Psoriasis